Clinical Trial Update: NHLBI and Cook Trans-Atrial Intra-Pericardial Tricuspid Annuloplasty (TRAIPTA) Early Feasibility Study [NA]

View source ↗

Summary

Clinical trial update shows the TRAIPTA Early Feasibility Study for tricuspid valve insufficiency is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tricuspid Valve Insufficiency

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Tricuspid Valve Insufficiency | NA | Status: SUSPENDED